In its pursuit of a cancer drug for pancreatic cancer and possibly ovarian cancer, Amplia has history on its side.

Miners alarmed at requirement to sign native title agreements with increasing royalty payments to groups asserting ...

ASX falls after Wall Street sell-off, with Nvidia, Microsoft sliding and Bitcoin tumbling as traders take profits.

Workplace Relations Minister Murray Watt says Australians do not want “robots making arbitrary decisions about workers’ ...

Felix Gold has laid its antimony ambitions bare, targeting 2025 restart of historic Scrafford mine in Alaska after this ...

ASX 200 drops as Santa rally fades, but energy, gold and Brainchip shine while Apollo's Slok backs US economy.

Dimerix (ASX:DXB) secured orphan drug designation for the treatment in the US and Europe, opening the door to a faster ...

Telix CEO Chris Behrenbruch has been awarded a 68% base pay rise ahead of expected FDA approval of its kidney cancer ...

The gas market in 2024 offered both challenges and opportunities, here are the companies that threaded the needle and ...

Gold benefits from central bank buying and rate cuts, while copper shows long-term promise, with a broker backing both for ...

After a stellar 2024 for recovering small to mid caps sector, our experts scour the sector for more overlooked nuggets.

There are no dead-certs in small-cap investing, but here are some plays that just might rise and shine in 2025.